Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from your editor.
View a sample and get more information
August 21, 2015

Recent Stories of Interest

From Drug Benefit News - A new document containing clarifications to the Medicare Part D program’s “any willing pharmacy” requirement reminds plan sponsors that CMS is closely watching pharmacy network contracting, including those networks with preferred cost-sharing pharmacies. Although the guidance does not preclude Part D plan sponsors from offering pharmacy networks with preferred cost sharing, it implements a swift, two-day turnaround time for any willing pharmacy requests, which may be a direct result of the concerns brought forth earlier this year by the National Community Pharmacists Association (NCPA) after Aetna Inc. was at the center of a controversial network-related debacle. Read more

As health plans and PBMs await the approval of a second cholesterol-lowering… Read more

As expected, Regeneron Pharmaceuticals, Inc./Sanofi’s Praluent (alirocumab) on July 24 became the… Read more

Following up a $37 billion planned purchase of Humana Inc. by Aetna… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

August 28, 2015
FDA Approves Amgen PCSK9 Inhibitor

The FDA just approved the second PCSK9 inhibitor, Amgen's Repatha. Are you ready to control PCSK9 costs?

August 27, 2015
HRSA Posts 340B Guidance

HRSA published its long-awaited 340B program mega-guidance.

August 24, 2015
J.D. Power Study Shows Customers Are Generally Satisfied With Pharmacies

Study shows overall customer satisfaction with pharmacies remains fairly stable: Supermarkets, chains are up slightly, but scores for mail orders, mass merchandisers drop a bit

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?